Cyclacel Pharmaceuticals Common Stock

Cyclacel Pharmaceuticals (CYCC) currently reports a common stock of $5K as of March 2026. That compares with $200 in the prior-year period — up 2351.0% year over year. Use the charts on this page to explore Cyclacel Pharmaceuticals's common stock history and peer comparisons.

Cyclacel Pharmaceuticals's common stock increased from $200 to $5K — a 2351.0% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cyclacel Pharmaceuticals reported $5K in common stock as of March 2026. That compares with $200 in the prior-year period — up 2351.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $5K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cyclacel Pharmaceuticals, and consider following CYCC for alerts when major investors trade the stock.

Cyclacel Pharmaceuticals is classified in the Healthcare sector. On common stock, it currently shows $5K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CYCC with unrelated industries.